一氧化氮在阿尔茨海默病中的作用。
The effects of nitric oxide in Alzheimer's disease.
机构信息
Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou, Jiangsu Province, China.
Institute of Stroke Research, Soochow University, Suzhou, Jiangsu Province, China.
出版信息
Med Gas Res. 2024 Dec 1;14(4):186-191. doi: 10.4103/2045-9912.385939. Epub 2023 Sep 17.
Abstract
Alzheimer's disease (AD), the most prevalent cause of dementia, is a progressive neurodegenerative condition that commences subtly and inexorably worsens over time. Despite considerable research, a specific drug that can fully cure or effectively halt the progression of AD remains elusive. Nitric oxide (NO), a crucial signaling molecule in the nervous system, is intimately associated with hallmark pathological changes in AD, such as amyloid-beta deposition and tau phosphorylation. Several therapeutic strategies for AD operate through the nitric oxide synthase/NO system. However, the potential neurotoxicity of NO introduces an element of controversy regarding its therapeutic utility in AD. This review focuses on research findings concerning NO's role in experimental AD and its underlying mechanisms. Furthermore, we have proposed directions for future research based on our current comprehension of this critical area.
摘要
阿尔茨海默病（AD）是最常见的痴呆症病因，是一种进行性神经退行性疾病，其症状起初微妙，而后逐渐加重且不可逆转。尽管进行了大量研究，但仍未发现能够完全治愈或有效阻止 AD 进展的特定药物。一氧化氮（NO）是神经系统中一种至关重要的信号分子，与 AD 的标志性病理变化密切相关，如β淀粉样蛋白沉积和tau 磷酸化。几种 AD 的治疗策略都通过一氧化氮合酶/NO 系统发挥作用。然而，NO 的潜在神经毒性使得其在 AD 中的治疗应用存在争议。本综述重点关注有关 NO 在实验性 AD 中的作用及其潜在机制的研究发现。此外，我们根据对这一关键领域的现有理解，提出了未来研究的方向。
相似文献
1
The effects of nitric oxide in Alzheimer's disease.一氧化氮在阿尔茨海默病中的作用。
Med Gas Res. 2024 Dec 1;14(4):186-191. doi: 10.4103/2045-9912.385939. Epub 2023 Sep 17.
2
Nitric oxide: target for therapeutic strategies in Alzheimer's disease.一氧化氮：阿尔茨海默病治疗策略的靶点。
Curr Pharm Des. 2010;16(25):2837-50. doi: 10.2174/138161210793176590.
3
Key Peptides and Proteins in Alzheimer's Disease.阿尔茨海默病相关的关键肽和蛋白
Curr Protein Pept Sci. 2019;20(6):577-599. doi: 10.2174/1389203720666190103123434.
4
A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer's Disease.阿尔茨海默病的病理生理学和治疗干预的最新进展。
Curr Pharm Des. 2023;29(43):3428-3441. doi: 10.2174/0113816128264355231121064704.
5
Untangling amyloid-β, tau, and metals in Alzheimer's disease.厘清阿尔茨海默病中的淀粉样β、tau 和金属。
ACS Chem Biol. 2013 May 17;8(5):856-65. doi: 10.1021/cb400080f. Epub 2013 Mar 18.
6
Screening of treatment targets for Alzheimer's disease from the molecular mechanisms of impairment by β-amyloid aggregation and tau hyperphosphorylation.从β-淀粉样蛋白聚集和tau 过度磷酸化损伤的分子机制筛选阿尔茨海默病的治疗靶点。
Neurosci Bull. 2011 Feb;27(1):53-60. doi: 10.1007/s12264-011-1040-6.
7
Protein arginine methyltransferase 4 modulates nitric oxide synthase uncoupling and cerebral blood flow in Alzheimer's disease.精氨酸甲基转移酶 4 调节阿尔茨海默病中的一氧化氮合酶解偶联和脑血流。
J Cell Physiol. 2024 Jun;239(6):e30858. doi: 10.1002/jcp.30858. Epub 2022 Aug 29.
8
Recent Advances in Drug Development for Alzheimer's Disease: A Comprehensive Review.阿尔茨海默病药物研发的最新进展：全面综述
Int J Mol Sci. 2025 Apr 21;26(8):3905. doi: 10.3390/ijms26083905.
9
Reducing Aβ load and tau phosphorylation: Emerging perspective for treating Alzheimer's disease.降低β淀粉样蛋白负荷和tau蛋白磷酸化：治疗阿尔茨海默病的新视角
Eur J Pharmacol. 2015 Oct 5;764:571-581. doi: 10.1016/j.ejphar.2015.07.043. Epub 2015 Jul 21.
10
Clearance of Amyloid Beta and Tau in Alzheimer's Disease: from Mechanisms to Therapy.阿尔茨海默病中β淀粉样蛋白和tau 的清除：从机制到治疗。
Neurotox Res. 2018 Oct;34(3):733-748. doi: 10.1007/s12640-018-9895-1. Epub 2018 Apr 7.
引用本文的文献
1
Advances in Collateral Neuroimaging for Acute Ischemic Stroke: Redefining Time and Tissue Windows in the Reperfusion Era.急性缺血性卒中侧支神经影像学进展：在再灌注时代重新定义时间和组织窗
J Neuroimaging. 2025 Jul-Aug;35(4):e70079. doi: 10.1111/jon.70079.
2
Rhein Inhibits Microglia-Mediated Neuroinflammation and Neuronal Damage of Alzheimer's Disease via Regulating the Glutamine-Aspartate-Arginine-NO Metabolic Pathway.大黄酸通过调节谷氨酰胺-天冬氨酸-精氨酸-一氧化氮代谢途径抑制小胶质细胞介导的阿尔茨海默病神经炎症和神经元损伤。
Int J Mol Sci. 2025 Jul 3;26(13):6404. doi: 10.3390/ijms26136404.
3
Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System.稳定的胃十五肽BPC 157作为治疗和安全关键：控制和调节血管生成及一氧化氮系统的特殊有益多效性作用
Pharmaceuticals (Basel). 2025 Jun 19;18(6):928. doi: 10.3390/ph18060928.
4
Microglial pro-inflammatory mechanisms induced by monomeric C-reactive protein are counteracted by soluble epoxide hydrolase inhibitors.可溶性环氧化物水解酶抑制剂可抵消单体C反应蛋白诱导的小胶质细胞促炎机制。
Int Immunopharmacol. 2025 May 16;155:114644. doi: 10.1016/j.intimp.2025.114644. Epub 2025 Apr 10.
5
Nanomaterials as medicinal gas sensors described by density functional theory: a comprehensive review.基于密度泛函理论描述的作为医用气体传感器的纳米材料：综述
Med Gas Res. 2025 Sep 1;15(3):435-441. doi: 10.4103/mgr.MEDGASRES-D-24-00121. Epub 2025 Feb 7.
6
Recent advances in immunotherapy targeting amyloid-beta and tauopathies in Alzheimer's disease.阿尔茨海默病中针对β-淀粉样蛋白和tau蛋白病的免疫治疗新进展。
Neural Regen Res. 2026 Feb 1;21(2):577-587. doi: 10.4103/NRR.NRR-D-24-00846. Epub 2025 Jan 29.
7
The compound (E)-2-(3,4-dihydroxystyryl)-3-hydroxy-4H-pyran-4-one alleviates neuroinflammation and cognitive impairment in a mouse model of Alzheimer's disease.化合物（E）-2-（3,4-二羟基苯乙烯基）-3-羟基-4H-吡喃-4-酮可减轻阿尔茨海默病小鼠模型中的神经炎症和认知障碍。
Neural Regen Res. 2025 Nov 1;20(11):3330-3344. doi: 10.4103/NRR.NRR-D-23-01890. Epub 2024 Jul 10.
8
Glucocorticoid receptor signaling in the brain and its involvement in cognitive function.大脑中的糖皮质激素受体信号传导及其与认知功能的关系。
Neural Regen Res. 2025 Sep 1;20(9):2520-2537. doi: 10.4103/NRR.NRR-D-24-00355. Epub 2024 Sep 6.
9
Novel genes involved in vascular dysfunction of the middle temporal gyrus in Alzheimer's disease: transcriptomics combined with machine learning analysis.参与阿尔茨海默病中颞叶回血管功能障碍的新基因：转录组学结合机器学习分析
Neural Regen Res. 2025 Dec 1;20(12):3620-3634. doi: 10.4103/NRR.NRR-D-23-02004. Epub 2024 Jul 29.
本文引用的文献
1
The Roles of the Amyloid Beta Monomers in Physiological and Pathological Conditions.淀粉样β单体在生理和病理条件下的作用。
Biomedicines. 2023 May 10;11(5):1411. doi: 10.3390/biomedicines11051411.
2
Probing differences among Aβ oligomers with two triangular trimers derived from Aβ.用两个源自 Aβ 的三角形三聚体探测 Aβ 寡聚物的差异。
Proc Natl Acad Sci U S A. 2023 May 30;120(22):e2219216120. doi: 10.1073/pnas.2219216120. Epub 2023 May 22.
3
Effect of β-amyloid on blood-brain barrier properties and function.β-淀粉样蛋白对血脑屏障特性及功能的影响。
Biophys Rev. 2023 Apr 5;15(2):183-197. doi: 10.1007/s12551-023-01052-x. eCollection 2023 Apr.
4
Aβ-oligomers: A potential therapeutic target for Alzheimer's disease.β-淀粉样寡聚体：阿尔茨海默病的潜在治疗靶点。
Int J Biol Macromol. 2023 Jun 1;239:124231. doi: 10.1016/j.ijbiomac.2023.124231. Epub 2023 Mar 28.
5
The role of ADAM17 in cerebrovascular and cognitive function in the APP/PS1 mouse model of Alzheimer's disease.ADAM17在阿尔茨海默病APP/PS1小鼠模型的脑血管和认知功能中的作用。
Front Mol Neurosci. 2023 Mar 2;16:1125932. doi: 10.3389/fnmol.2023.1125932. eCollection 2023.
6
Innate Immune Cell Death in Neuroinflammation and Alzheimer's Disease.固有免疫细胞死亡在神经炎症和阿尔茨海默病中的作用。
Cells. 2022 Jun 10;11(12):1885. doi: 10.3390/cells11121885.
7
γ-Glutamylcysteine attenuates amyloid-β oligomers-induced neuroinflammation in microglia via blocking NF-κB signaling pathway.γ-谷氨酰半胱氨酸通过阻断核因子κB信号通路减轻小胶质细胞中淀粉样β寡聚体诱导的神经炎症。
Chem Biol Interact. 2022 Aug 25;363:110019. doi: 10.1016/j.cbi.2022.110019. Epub 2022 Jun 15.
8
Antioxidant and Neuroprotective Effects of Carnosine: Therapeutic Implications in Neurodegenerative Diseases.肌肽的抗氧化和神经保护作用：对神经退行性疾病的治疗意义
Antioxidants (Basel). 2022 Apr 26;11(5):848. doi: 10.3390/antiox11050848.
9
CaMKIIα Signaling Is Required for the Neuroprotective Effects of Dl-3-n-Butylphthalide in Alzheimer's Disease.钙调蛋白激酶 IIα 信号通路对于 Dl-3-正丁基苯酞在阿尔茨海默病中的神经保护作用是必需的。
Mol Neurobiol. 2022 Jun;59(6):3370-3381. doi: 10.1007/s12035-022-02777-8. Epub 2022 Mar 19.
10
Modifying the diet and gut microbiota to prevent and manage neurodegenerative diseases.通过调整饮食和肠道微生物群来预防和管理神经退行性疾病。
Rev Neurosci. 2022 Mar 21;33(7):767-787. doi: 10.1515/revneuro-2021-0146. Print 2022 Oct 26.
Zotero 插件